While #InternationalClinicalTrialsDay has just passed, the importance of clinical trials — and the partnerships that make them possible — is front of mind every day at Omico. We’d like to take a moment to thank Merck for their partnership, commitment and energy in helping

📰 Omico’s May newsletter is out now. Want to keep up with our work to advance precision oncology? Our newsletter brings you regular updates on Omico’s national initiatives, events, collaborations and progress — all aimed at improving access to precision oncology in Australia.

Absolutely wonderful talk for the Big Ideas seminar seriesby Prof Karen Canfell AC on eliminating cervical cancer. Kudos! Omico Australia UNSW University of Sydney

Different roles, shared purpose: Omico loves Rare Cancers Australia's drive to make things better for people living with cancer. Please share and take part in this important survey 👇

#Honoured and #humbled to have been awarded #FASCO and #ASCO25. My thanks to my friends and colleagues for your overwhelming support along the way 😊 #sarcoma #LCSM #InternationalAffairsCommittee #drugdevelopment #precisiononcology

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

🚨 ASCO #ASCO25 was absolutely incredible! 🧬✨ So many groundbreaking advances in oncology and exciting publications that are going to change patient care. 👉Sharing the key ones below The Lancet The Lancet Oncology Journal of Clinical Oncology JAMA JAMA Oncology Cancer Discovery - Also added the

🧬 TWEETORIAL/X'torial: Why Every Rare Cancer Patient Deserves Molecular Profiling 🧬 1/15 🚨 Here's a shocking fact: Rare cancers make up 25% of ALL cancer cases, yet most patients never get the molecular testing that could save their lives. 👉In our policy & practice paper -

Tour de Cure is an amazingly committed and hard-working cancer community. It was fun to attend their annual Snow Ball event in Sydney on Friday. I was very humbled to hear the announcement of the inaugural Scolyer Award for cancer researchers. I also felt very touched to receive

Congratulations to Hayden Snow and David Gyorki on the publication of their latest paper in collaboration with the TARPSWG. A major step forward for improving outcomes for retroperitoneal sarcoma through international collaboration. Read here: journals.lww.com/annalsofsurger…

My abstract is already submitted. And yours?

Brian is living proof of the importance of clinical trials in saving lives. Three years ago he was diagnosed with an incurable blood cancer. Soon after commencing chemotherapy and radiation therapy, Brian took part in a pilot study with CCLHD. Learn more: medicalresearch.nsw.gov.au/clinical-trial…

well, this is exciting: now the microbiome becomes much more interesting...rdcu.be/ewfwC

"I am impelled to tell you how much I have come to admire your intellect, your drive, and your honesty... If the rabble continues to occupy itself with you, then simply don't read that hogwash" - Albert Einstein to Marie Curie. Read the letter: bit.ly/2MKClAi

In a new #ScienceExpertVoices article, researcher Melanie Mitchell takes a look at why #AI chatbots lie to us. scim.ag/3GGqSnh

Such an important topic!

Important #RWE from our Czech colleagues. Again, access to experimental treatments is the defining bottleneck in MTB-driven care. #PrecisionMedicine

In 1943, physics laureate Erwin Schrödinger delivered three lectures at DIAS, which turned into his book, 'What is Life?' Multiple scientists, including medicine laureates Francis Crick and James Watson, were influenced by the book, and research still builds upon it.